THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors

被引:172
作者
Alexander, Stephen P. H. [1 ]
Fabbro, Doriano [2 ]
Kelly, Eamonn [3 ]
Marrion, Neil V. [3 ]
Peters, John A. [4 ,5 ]
Faccenda, Elena [6 ]
Harding, Simon D. [6 ]
Pawson, Adam J. [6 ]
Sharman, Joanna L. [6 ]
Southan, Christopher [6 ]
Davies, Jamie A. [6 ]
机构
[1] Univ Nottingham, Sch Life Sci, Sch Med, Nottingham NG7 2UH, England
[2] PIQUR Therapeut, CH-4057 Basel, Switzerland
[3] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol BS8 1TD, Avon, England
[4] Univ Dundee, Ninewells Hosp, Med Educ Inst, Neurosci Div, Dundee DD1 9SY, Scotland
[5] Univ Dundee, Sch Med, Dundee DD1 9SY, Scotland
[6] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland
关键词
D O I
10.1111/bph.13876
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Concise Guide to PHARMACOLOGY 2017/18 provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13876/full. Catalytic receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: G protein-coupled receptors, ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2017, and supersedes data presented in the 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature Committee of the Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
引用
收藏
页码:S225 / S271
页数:47
相关论文
共 21 条
[1]  
Berger C, 2013, Patent, Patent No. [US8388968, 8388968]
[2]  
Breitenstein W, 2015, Patent, Patent No. [WO2015189265, 2015189265]
[3]  
Cardarelli JM, 2010, Patent, Patent No. [US7662381, 7662381]
[4]  
Cohen ES, 2012, Patent, Patent No. [US8263075, 8263075]
[5]  
Coller BS, 1999, Patent, Patent No. [US5976532, 5976532]
[6]  
Goldstein NI, 2006, Patent, Patent No. [US7060808, 7060808]
[7]  
Gomez-Nicola D., 2014, MICROGLIA HLTH DIS, P437
[8]   Design of MHC class II (DR4) ligands using conformationally restricted imino acids at p3 and p5 [J].
Hanson, GJ ;
Vuletich, JL ;
Bedell, LJ ;
Bono, CP ;
Howard, SC ;
Welply, JK ;
Woulfe, SL ;
Zacheis, ML .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (16) :1931-1936
[9]  
Igawa T., 2013, Patent, Patent No. 8562991
[10]  
Jardieu PM, 2004, Patent, Patent No. [US6703018, 6703018]